ArticleTranslational andrology and urology2025
Analysis of the burden of disease for male infertility globally and in China from 1990 to 2021.
Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Diagnostic classification and medical decision of idiopathic asthenozoospermia based on metabolomics analysis of seminal plasma.Journal of endocrinological investigation · 2026Article
- Sperm DNA Fragmentation in Native Semen: A Reflection of Apoptotic and Non-Viable Spermatozoa and Its Implications for Assisted Reproduction.International journal of molecular sciences · 2026Article
- A Scoping Review of Male Fertility Assessment and Treatment Across Historical and Contemporary Paradigms.Andrology · 2026Article
- China-East Asia comparison of male infertility burden and trend prediction: evidence from GBD 2023.Translational andrology and urology · 2026Article
- Long-Term Epidemiological Trends and Regional Disparities in Male Infertility in Central Asia (1991-2023).International journal of environmental research and public health · 2026Article
- ABO blood group distribution and infertility risk in Southern China: a retrospective analysis of the Ganzhou Region.Journal of assisted reproduction and genetics · 2026Article
- Exploratory Review on Male Fertility Potential of Acetyl-Eugenol: Mechanistic Insights, Experimental Evidence, and Therapeutic Prospects.Journal of experimental pharmacology · 2026Review
- Trends in male infertility burden in South Asia: a 30-year analysis of DALYs, prevalence, and future projections based on GBD 2021.Frontiers in reproductive health · 2025Article
- Prevalence of Y chromosome microdeletions of the azoospermia factor region among Libyan men with infertility.Medicine internationalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Infertility affects one in six couples globally, with male infertility contributing to 50% of cases. Despite its high prevalence, male infertility is underexplored in some regions due to cultural and societal factors. Epidemiological data remain sparse and inconsistent. This study uses Global Burden of Disease (GBD) 2021 data to assess the global and Chinese burden of male infertility and project future trends. Methods: Using the GBD 2021 dataset, we analyze global male infertility trends from 1990 to 2021 across different subgroups (age, region, and country), focusing on prevalence, disability-adjusted life years (DALYs), and their corresponding age-standardized rates (ASRs), and compare these trends with China. We examine the correlation between the Socio-Demographic Index (SDI) and the burden of male infertility at national and regional levels. Spearman's rank correlation assesses the relationship between ASRs and SDI. Decomposition analysis identifies drivers of the growing male infertility burden globally, in China, and across SDI regions. The slope index of inequality (SII) and the concentration index (CII) quantify global health inequalities, and the Bayesian-Aperiodic-People-Cohort (BAPC) model predicts future trends in male infertility prevalence and DALYs globally and in China. Results: In 2021, the global prevalence of male infertility surpassed 55 million cases, with over 300,000 DALYs. China accounted for approximately 20% of the global burden, with ASRs significantly exceeding the global average. Globally, male infertility prevalence and DALYs increased steadily from 1990 to 2021, particularly in low and low-middle SDI regions, such as South Asia, Southeast Asia, and Latin America. In contrast, China exhibited a stable trend with a gradual decline after 2008. Population growth was identified as the primary driver of global prevalence increases, while age-related factors played a more significant role in China. South and East Asia reported the highest absolute numbers of prevalence cases and DALYs, contributing to half of the global burden. However, the highest ASRs for prevalence and DALYs were recorded in Eastern Europe and Western Sub-Saharan Africa, reaching 1.5 times the global average. Conclusions: This study underscores the increasing global burden of male infertility, accompanied by pronounced disparities across regions and socioeconomic groups. While the burden in China shows signs of decline, low and low-middle SDI regions continue to face rising prevalence and DALYs. Official attention, along with a comprehensive approach to managing environmental factors, lifestyle changes, and sexually transmitted diseases (STDs), is essential to address these disparities and mitigate the growing global burden of male infertility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.